We wish to announce that pursuant to Chapter 9, Paragraph 9.19(5) of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad, Sunway Holdings Sdn Bhd (“SunH”), a wholly-owned subsidiary of the Company has on 11 August 2016, acquired 2 ordinary shares of RM1/- each, representing 100% of the total issued and paid-up share capital of Sunway Pharma Sdn Bhd from Sunway Marketing Sdn Bhd, a wholly-owned subsidiary of SunH, for a total cash consideration of RM2/- (“Reorganisation Exercise”).

Sunway Pharma was incorporated on 11 January 2008 and its authorised and paid-up share capital are RM100,000/- and RM2/- respectively. Sunway Pharma is presently dormant and Its intended principal activities are retail, trading, marketing, import, distribution, manufacturing and online selling of pharmaceutical products.

Upon completion of the Reorganisation Exercise, Sunway Pharma has become a direct subsidiary of SunH.

The Reorganisation Exercise is not expected to have any effect on the issued and paid-up capital of Sunway or Sunway’s substantial shareholders’ shareholdings or any material effect on the earnings, net assets or gearing of Sunway on a consolidated basis.

None of the directors or substantial shareholders of Sunway or persons connected with them has any interest, whether direct or indirect in the Reorganisation Exercise.

This announcement is dated 11 August 2016.